Lucem Health, a leading provider of transformational clinical AI technology and solutions, recently announced that it has closed a Series A funding round of $7.7 million. Led by Mayo Clinic, Granger Management and Mercy (St Louis), this funding round attracted existing investor Rally Ventures and will be used to advance the development of Lucem Health’s platform for clinical AI solution deployment, grow the company’s solution portfolio, and expand its sales and marketing capacity.
Lucem Health’s platform reveals clinically meaningful insights to health care professionals, granting them greater accuracy when detecting diseases earlier and optimizing care delivery. This ultimately leads to improved patient health outcomes, a better experience for physicians and providers, and greater financial value for health organizations. The company recently launched Lucem Health Reveal, a family of solutions that use readily available clinical data to help identify patients who may be at a higher risk of chronic or serious illnesses.
The use of AI technology into clinical practice has allowed greater accuracy and increased the likelihood of better health outcomes. This has created more opportunities in the healthcare field for personalization, automation and cost reduction. This is all possible due to the teams of data scientists, clinicians, and software engineers that have come together to form Lucem Health. With the help of this powerhouse, the company is already helping health care providers and organizations worldwide prepare for the availability of transformative AI clinical care.
